Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01900418 · ClinicalTrials.gov registry record · NA
Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT01900418 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 78 participants.
The verdict
NCT01900418, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
For post-menopausal women diagnosed with hormone-receptor positive breast cancer tumors, aromatase inhibitors (AIs) are the standard adjuvant hormone treatment to prolong disease-free survival and time-to-recurrence. Unfortunately, joint pain/stiffness/achiness (arthralgia) is a common side-effect of AIs. This "proof-of-concept" study explores how an evidence-based physical activity (PA) program- the Arthritis Foundation's Walk with Ease (WWE) program- can be adapted for breast cancer survivors on AI therapy to: 1) Help them maintain or achieve recommended levels of PA, 2) reduce their joint pain/stiffness/achiness, and 3) thereby enable them to remain on AI therapy as prescribed.
Interventions
- BEHAVIORAL Walk with Ease
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01900418
The ClinicalTrials.gov registry entry for NCT01900418 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Walk with Ease is the first listed.
NCT01900418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01900418 about?
NCT01900418 is a clinical study titled "Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy". For post-menopausal women diagnosed with hormone-receptor positive breast cancer tumors, aromatase inhibitors (AIs) are the standard adjuvant hormone treatment to prolong disease-free survival and time-to-recurrence. Unfortunately, joint pain/stiffness/achiness (arthralgia) is a common side-effect o...
What is the current status of trial NCT01900418?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2013-08. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01900418?
The interventions under investigation include: Walk with Ease (BEHAVIORAL).
Who is sponsoring clinical trial NCT01900418?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.